Conivaptan hydrochloride is a non-peptide dual inhibitor of the V1a and V2 receptors of arginine vasopressin (AVP), It is mainly used for the treatment of inpatients with normal blood volume hyponatremia (often associated with abnormal vasopressin secretion syndrome, hypothyroidism, hypoadrenal disease or lung disease).